Search Results - "BREDENFELD, Henning"
-
1
Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
Published in Journal of clinical oncology (20-01-2008)“…Lymphocyte-predominant Hodgkin's lymphoma (LPHL) is rare and differs in histologic and clinical presentation from classical Hodgkin's lymphoma (cHL). To shed…”
Get full text
Journal Article -
2
Hodgkin's Lymphoma in Adolescents Treated With Adult Protocols: A Report From the German Hodgkin Study Group
Published in Journal of clinical oncology (20-12-2009)“…PURPOSE The standard of care for adolescent patients with Hodgkin's lymphoma (HL) is undefined, particularly the choice between pediatric and adult protocols…”
Get full text
Journal Article -
3
Severe Pulmonary Toxicity in Patients With Advanced-Stage Hodgkin's Disease Treated With a Modified Bleomycin, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, and Gemcitabine (BEACOPP) Regimen Is Probably Related to the Combination of Gemcitabine and Bleomycin: A Report of the German Hodgkin's Lymphoma Study Group
Published in Journal of clinical oncology (15-06-2004)“…To investigate a new effective, nonleukemogenic polychemotherapy regimen, BAGCOPP (bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine,…”
Get full text
Journal Article -
4
A Contribution to Solve the Problem of the Need for Consolidative Radiotherapy after Intensive Chemotherapy in Advanced Stages of Hodgkin's Lymphoma—Analysis of a Quality Control Program Initiated by the Radiotherapy Reference Center of the German Hodgkin Study Group (GHSG)
Published in International journal of radiation oncology, biology, physics (15-11-2007)“…Purpose The role of radiotherapy (RT) after intensive chemotherapy in patients with advanced stage Hodgkin's lymphoma (HL) is still unclear. The German Hodgkin…”
Get full text
Journal Article -
5
Radiotherapy Does Not Influence the Severe Pulmonary Toxicity Observed With the Administration of Gemcitabine and Bleomycin in Patients With Advanced-Stage Hodgkin's Lymphoma Treated With the BAGCOPP Regimen: A Report by the German Hodgkin's Lymphoma Study Group
Published in International journal of radiation oncology, biology, physics (2008)“…Purpose To evaluate the effect of radiotherapy on the severe pulmonary toxicity observed in the pilot study of BAGCOPP (bleomycin, doxorubicin,…”
Get full text
Journal Article -
6
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma
Published in Blood (08-12-2011)“…Approximately 20% of all Hodgkin lymphoma (HL) patients are older than 60 years and have a poor prognosis, mainly because of increased treatment-related…”
Get full text
Journal Article -
7
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial
Published in International journal of antimicrobial agents (01-02-2012)“…Abstract Patients receiving high-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) are at high risk of infections,…”
Get full text
Journal Article -
8
Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas
Published in Leukemia & lymphoma (01-08-2010)“…Our understanding of the biology underlying lymphoma is continually increasing and leading to improved treatment strategies for affected patients. However,…”
Get full text
Journal Article -
9
PVAG (Prednisone, Vinblastine, Doxorubicin and Gemcitabine) In Elderly Patients with Intermediate or Advanced Stage Hodgkin Lymphoma: Final Results of a Phase II Study of the German Hodgkin Study Group (GHSG)
Published in Blood (19-11-2010)“…Abstract 2827 About 20% of all patients diagnosed with Hodgkin lymphoma (HL) are older than 60 years. These patients have a rather poor prognosis, particularly…”
Get full text
Journal Article -
10
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma
Published in Leukemia & lymphoma (01-01-2008)“…Early treatment failure is still a clinical challenge despite high cure rates in Hodgkin lymphoma (HL) patients. To identify the biological risk factors…”
Get full text
Journal Article -
11
Hodgkin Lymphoma in Adolescents Treated with Adult Protocols: An Analysis From the German Hodgkin Study Group (GHSG)
Published in Blood (20-11-2009)“…Abstract 719 The standard of care for adolescent Hodgkin lymphoma (HL) patients is undefined, particularly the choice between adult and pediatric protocols. We…”
Get full text
Journal Article -
12
Allogeneic Stem Cell Transplantation for Relapsed Hodgkin's Disease - a Single Centre Experience
Published in Blood (16-11-2008)“…Hodgkin's disease can be cured by chemotherapy in the majority of cases. However a small proportion of patients show an aggressive course with multiple…”
Get full text
Journal Article -
13
A Comparison of Outcome and Second Malignancies in Adolescents and Adult Patients with Hodgkin's Lymphoma (HL). Results from the German Hodgkin Study Group
Published in Blood (16-11-2005)“…Introduction: Whether adolescent (alc) patients with HL represent a distinct patient group, requiring a therapy strategy separated from adults, is currently…”
Get full text
Journal Article -
14
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study
Published in Haematologica (Roma) (01-04-2006)“…Department I of Internal Medicine, University of Cologne, Cologne, Germany. a.engert@uni-koeln.de The primary endpoint of this feasibility study was to…”
Get full text
Journal Article -
15
Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group
Published in Blood (16-11-2006)“…Introduction: Lymphocyte predominant Hodgkin lymphoma (LPHL) differs in histological and clinical presentation from classical Hodgkin lymphoma (cHL). Treatment…”
Get full text
Journal Article -
16
Pegfilgrastim Supports Delivery of BEACOPP Chemotherapy Administered Every 14 Days
Published in Blood (16-11-2004)“…The German Hodgkin's Lymphoma Study Group has previously demonstrated that dose-escalated BEACOPP chemotherapy administered every 21 days with filgrastim…”
Get full text
Journal Article -
17
Complete Spontaneous Remission of an Aggressive Non-Hodgkin's Lymphoma with Primary Manifestation in the Oral Cavity
Published in Leukemia & lymphoma (01-01-2004)“…A well-documented case of complete spontaneous remission of a histopathologically supported highly malignant B-cell Non-Hodgkin's lymphoma with primary…”
Get full text
Journal Article -
18
Abdominal lymphoma staging : Is MR imaging with T2-weighted turbo-spin-echo sequence a diagnostic alternative to contrast-enhanced spiral CT?
Published in Journal of computer assisted tomography (01-09-2000)“…To evaluate the diagnostic value of MR imaging in abdominal lymphoma staging, in comparison with that of the established spiral CT, within the context of a…”
Get full text
Journal Article